Home  >  Products  >  CDCA7L (cell division cycle associated 7-like) Blocking Peptide (the middle region of CDCA7L)(100ug)
CDCA7L (cell division cycle associated 7-like) Blocking Peptide (the middle region of CDCA7L)(100ug)

CDCA7L (cell division cycle associated 7-like) Blocking Peptide (the middle region of CDCA7L)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CDCA7L Antibody(ARP57292_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP57292
Size: 100ug
Weight: 46kDa
Gene: 55536
Format: Lyophilized powder
Target: CDCA7L plays a role in transcriptional regulation as a repressor that inhibits monoamine oxidase A (MAOA) activity and gene expression by binding to the promoter.CDCA7L plays an important oncogenic role in mediating the full transforming effect of MYC in medulloblastoma cells. CDCA7L is involved in apoptotic signaling pathways. CDCA7L may act downstream of P38-kinase and BCL-2, but upstream of CASP3/caspase-3 as well as CCND1/cyclin D1 and E2F1.
Alternative names: DKFZp762L0311; JPO2; R1; RAM2